Dongzhou Liu

This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongzhou Liu. Retrieved from https://idiyas.com/inventor/dongzhou-liu-lscdtmdl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dongzhou Liu - Innovator in Pharmaceutical Development

Introduction

Dongzhou Liu is a prominent inventor known for his contributions to the pharmaceutical industry. He is currently associated with Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., where he focuses on innovative drug development. His work has significantly impacted the field of medicine, particularly in the area of dual agonists.

Latest Patents

Dongzhou Liu holds a patent for a GLP-1/GIP dual agonist, which includes the preparation method and its use. This invention represents a significant advancement in therapeutic options for metabolic diseases. The patent showcases his expertise and commitment to improving patient outcomes through innovative solutions.

Career Highlights

Throughout his career, Dongzhou Liu has demonstrated a strong dedication to research and development. His work at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. has positioned him as a key player in the pharmaceutical sector. With a total of 1 patent, he continues to push the boundaries of what is possible in drug formulation and delivery.

Collaborations

Dongzhou Liu collaborates with talented professionals in his field, including Nan Zhang and Chunhua Jiang. These partnerships enhance the innovative capacity of his projects and contribute to the overall success of their endeavors.

Conclusion

Dongzhou Liu is a noteworthy inventor whose work in the pharmaceutical industry exemplifies innovation and dedication. His contributions, particularly in the development of dual agonists, highlight the importance of research in advancing medical treatments. His ongoing efforts will undoubtedly continue to shape the future of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…